2020
Effect of a 12-Week Pilates Pelvic Floor-Strengthening Program on Short-Term Measures of Stress Urinary Incontinence in Women: A Pilot Study
Hein JT, Rieck TM, Dunfee HA, Johnson DP, Ferguson JA, Rhodes DJ. Effect of a 12-Week Pilates Pelvic Floor-Strengthening Program on Short-Term Measures of Stress Urinary Incontinence in Women: A Pilot Study. Journal Of Alternative And Complementary Medicine 2020, 26: 158-161. PMID: 31916840, PMCID: PMC7044776, DOI: 10.1089/acm.2019.0330.Peer-Reviewed Original Research
2019
Impact of short-term low-dose tamoxifen on molecular breast imaging background parenchymal uptake: a pilot study
Hruska CB, Hunt KN, Conners AL, Geske JR, Brandt KR, Degnim AC, Vachon CM, O’Connor M, Rhodes DJ. Impact of short-term low-dose tamoxifen on molecular breast imaging background parenchymal uptake: a pilot study. Breast Cancer Research 2019, 21: 38. PMID: 30850011, PMCID: PMC6408779, DOI: 10.1186/s13058-019-1120-5.Peer-Reviewed Original ResearchConceptsLow-dose tamoxifenMolecular breast imagingBackground parenchymal uptakeOral tamoxifenParenchymal uptakeBreast cancer risk reductionBreast cancer risk factorsEffectiveness of tamoxifenCancer risk factorsCancer risk reductionBreast cancer historyShort-term interventionMean ageCancer historyRisk factorsBreast fibroglandular tissueTamoxifenMolecular breastAverage countStudy participantsSubcutaneous fatPilot studyWomenT-testIntervention
2017
Patient Acceptance of Half-dose Vs. Half-time Molecular Breast Imaging
Swanson TN, Tran TD, Hruska CB, Solberg CM, Rhodes DJ, Hunt KN, Conners AL, O'Connor MK. Patient Acceptance of Half-dose Vs. Half-time Molecular Breast Imaging. Journal Of Medical Imaging And Radiation Sciences 2017, 49: 39-43. PMID: 30479286, DOI: 10.1016/j.jmir.2017.08.003.Peer-Reviewed Original ResearchConceptsMolecular breast imagingExact testFisher's exact testDuration of examinationBreast imagingPatients' opinionsPatient acceptanceDose reductionExamination comfortMost womenPatient comfortFemale volunteersRadiation doseExamination typesDoseExamination preferencesImagingPatientsGroupNumber of strategiesSurvey responsesVolunteersWomen
2016
Dense Breasts: What Do Our Patients Need to Be Told and Why?
Throckmorton AD, Rhodes DJ, Hughes KS, Degnim AC, Dickson-Witmer D. Dense Breasts: What Do Our Patients Need to Be Told and Why? Annals Of Surgical Oncology 2016, 23: 3119-3127. PMID: 27401446, DOI: 10.1245/s10434-016-5400-3.Peer-Reviewed Original ResearchConceptsBreast cancer prevention strategiesEvidence-based consensus guidelinesDense breastsBreast cancer risk assessmentOnly risk factorCancer prevention strategiesCancer risk assessmentDelaying diagnosisCertain patientsConsensus guidelinesRisk factorsDensity notificationSupplemental imagingPrevention strategiesPatientsBreast densityBreastRisk assessmentCancerDiagnosisWomen
2015
Effect of Menstrual Cycle Phase on Background Parenchymal Uptake at Molecular Breast Imaging
Hruska CB, Conners AL, Vachon CM, O'Connor MK, Shuster LT, Bartley AC, Rhodes DJ. Effect of Menstrual Cycle Phase on Background Parenchymal Uptake at Molecular Breast Imaging. Academic Radiology 2015, 22: 1147-1156. PMID: 26112057, PMCID: PMC4532620, DOI: 10.1016/j.acra.2015.04.003.Peer-Reviewed Original ResearchMeSH KeywordsAdultBreastBreast DensityChromatography, LiquidCohort StudiesEstradiolEstroneFemaleFollicle Stimulating HormoneFollicular PhaseHumansLuteal PhaseMammographyMiddle AgedMolecular ImagingPremenopauseProgesteroneProspective StudiesRadiopharmaceuticalsSex Hormone-Binding GlobulinTandem Mass SpectrometryTechnetium Tc 99m SestamibiTestosteroneConceptsBackground parenchymal uptakeMolecular breast imagingMenstrual cycle phaseLuteal phaseMenstrual cycleNondense breastsFollicular phaseHormone levelsParenchymal uptakeDense breastsExogenous hormone useRegular menstrual cyclesLevels of TCCycle phaseNormal fibroglandular tissuePremenopausal volunteersPremenopausal womenHormone useSpearman correlation coefficientBreast imagingStudy radiologistsMammographic densityBreastFibroglandular tissueWomenDiagnostic workup and costs of a single supplemental molecular breast imaging screen of mammographically dense breasts.
Hruska CB, Conners AL, Jones KN, O'Connor MK, Moriarty JP, Boughey JC, Rhodes DJ. Diagnostic workup and costs of a single supplemental molecular breast imaging screen of mammographically dense breasts. American Journal Of Roentgenology 2015, 204: 1345-53. PMID: 26001247, PMCID: PMC5036572, DOI: 10.2214/ajr.14.13306.Peer-Reviewed Original ResearchConceptsBenign biopsy rateDiagnostic workupBiopsy rateDense breastsAdditional diagnostic workupCancer detection rateMammography of womenBreast imaging examinationsPositive predictive valueDual-head gamma cameraImaging examinationsPredictive valueMolecular breastBiopsyPatientsWorkupBreastScreening mammographyCancerWomenMammographyMalignancyReference standardGamma cameraDetection rateAwareness of Breast Density and Its Impact on Breast Cancer Detection and Risk
Rhodes DJ, Radecki Breitkopf C, Ziegenfuss JY, Jenkins SM, Vachon CM. Awareness of Breast Density and Its Impact on Breast Cancer Detection and Risk. Journal Of Clinical Oncology 2015, 33: 1143-1150. PMID: 25732156, PMCID: PMC4551864, DOI: 10.1200/jco.2014.57.0325.Peer-Reviewed Original ResearchMeSH KeywordsAwarenessBlack or African AmericanBreastBreast NeoplasmsCross-Sectional StudiesEarly Detection of CancerEducational StatusFemaleHealth Knowledge, Attitudes, PracticeHealthcare DisparitiesHispanic or LatinoHumansLogistic ModelsMammographyMass ScreeningMiddle AgedMultivariate AnalysisRisk FactorsSocial ClassUnited StatesWhite PeopleConceptsRace/ethnicityBD awarenessWhite non-Hispanic race/ethnicityCancer detectionPostmenopausal hormone therapyNational cross-sectional surveyNon-Hispanic race/ethnicityPrior breast biopsyBreast cancer detectionHealth care providersCross-sectional surveyBreast density informationMultivariable adjustmentHormone therapyDiagnostic evaluationCancer riskCare providersBreast biopsyConnecticut residentsBreast densityHigher household incomeProbability-based sampleHousehold incomeWomenRiskBackground parenchymal uptake during molecular breast imaging and associated clinical factors.
Hruska CB, Rhodes DJ, Conners AL, Jones KN, Carter RE, Lingineni RK, Vachon CM. Background parenchymal uptake during molecular breast imaging and associated clinical factors. American Journal Of Roentgenology 2015, 204: w363-70. PMID: 25714323, PMCID: PMC4423612, DOI: 10.2214/ajr.14.12979.Peer-Reviewed Original ResearchConceptsBackground parenchymal uptakePostmenopausal hormone therapyParenchymal uptakeBreast cancerMolecular breast imagingHormone therapyClinical factorsMammographic densityDense breastsBI-RADS density categoriesChi-square testMenopausal statusPatient characteristicsHormonal contraceptivesEligible participantsGail modelMenstrual cycleSubsequent riskPrevious mammogramsMolecular breastBreast implantsUnderlying causeCancerBreastWomen
2012
Evaluation of Molecular Breast Imaging in Women Undergoing Myocardial Perfusion Imaging with Tc-99m Sestamibi
Hruska CB, Rhodes DJ, Collins DA, Tortorelli CL, Askew JW, O'Connor MK. Evaluation of Molecular Breast Imaging in Women Undergoing Myocardial Perfusion Imaging with Tc-99m Sestamibi. Journal Of Women's Health 2012, 21: 730-738. PMID: 22404787, DOI: 10.1089/jwh.2011.3267.Peer-Reviewed Original ResearchConceptsMolecular breast imagingBreast diseaseBreast cancerDiagnostic yieldMyocardial perfusionHigh-risk benign breast lesionsMyocardial perfusion stress testingRecent negative mammogramStress myocardial perfusionHigh diagnostic yieldStress myocardial perfusion studyBenign breast lesionsNumber of cancersMyocardial perfusion studiesBreast imagingNew cancersRecent mammogramSestamibi injectionNegative mammogramUnnecessary workupPerfusion studiesBreast lesionsCancerIsotope injectionWomen
2010
Vulvovaginal Atrophy
Bride M, Rhodes DJ, Shuster LT. Vulvovaginal Atrophy. Mayo Clinic Proceedings 2010, 85: 87-94. PMID: 20042564, PMCID: PMC2800285, DOI: 10.4065/mcp.2009.0413.Peer-Reviewed Original ResearchConceptsVulvovaginal atrophyLocal estrogen treatmentBreast cancer treatmentGroup of womenWoman's life cycleSystemic estrogenUrinary frequencyPostmenopausal phaseVVA symptomsClinical findingsVaginal pHEstrogen treatmentUnderreported conditionVaginal wallVulvovaginal mucosaVaginal tissueChemotherapeutic agentsVaginal rugaeCancer treatmentAtrophySymptomsPrevalenceTreatmentWomenDyspareunia
2009
Premature menopause or early menopause: Long-term health consequences
Shuster LT, Rhodes DJ, Gostout BS, Grossardt BR, Rocca WA. Premature menopause or early menopause: Long-term health consequences. Maturitas 2009, 65: 161-166. PMID: 19733988, PMCID: PMC2815011, DOI: 10.1016/j.maturitas.2009.08.003.Peer-Reviewed Original ResearchConceptsPremature menopauseEarly menopauseAdverse outcomesEstrogen treatmentHealth consequencesLong-term health consequencesMayo Clinic Cohort StudyOnset of menopauseTime of menopauseCohort studyMedian ageOverall mortalityEstrogen deficiencyNatural menopauseCardiovascular diseaseLong-term consequencesCurrent evidenceMenopausePsychiatric diseasesNeurological diseasesHormonal mechanismsDiseaseWomenOutcomesEarly ageIncreased Mortality for Neurological and Mental Diseases following Early Bilateral Oophorectomy
Rivera CM, Grossardt BR, Rhodes DJ, Rocca WA. Increased Mortality for Neurological and Mental Diseases following Early Bilateral Oophorectomy. Neuroepidemiology 2009, 33: 32-40. PMID: 19365140, PMCID: PMC2697609, DOI: 10.1159/000211951.Peer-Reviewed Original ResearchConceptsAge 45 yearsBilateral oophorectomyReferent womenUnilateral oophorectomyMental diseasesBenign ovarian conditionsEarly bilateral oophorectomyTime of oophorectomyOnset of menopauseEffect of oophorectomyOophorectomy cohortOlmsted CountyCohort studyConcurrent hysterectomyOophorectomyBrain agingAge strataMortalityOvarian conditionContributory causeWomenDiseaseYearsSame populationHysterectomyIncreased cardiovascular mortality after early bilateral oophorectomy
Rivera CM, Grossardt BR, Rhodes DJ, Brown RD, Roger VL, Melton LJ, Rocca WA. Increased cardiovascular mortality after early bilateral oophorectomy. Menopause The Journal Of The North American Menopause Society 2009, 16: 15-23. PMID: 19034050, PMCID: PMC2755630, DOI: 10.1097/gme.0b013e31818888f7.Peer-Reviewed Original ResearchConceptsAge 45 yearsBilateral oophorectomyReferent womenCardiovascular diseaseUnilateral oophorectomyCardiovascular mortalityEstrogen treatmentEarly bilateral oophorectomyOnset of menopauseOophorectomy cohortCardiac mortalityOlmsted CountyCohort studyCerebrovascular causesOophorectomyAge strataMortalityDiseaseWomenMenopauseEstrogenTreatmentSame populationYearsCohort
2002
Identifying and Counseling Women at Increased Risk for Breast Cancer
Rhodes DJ. Identifying and Counseling Women at Increased Risk for Breast Cancer. Mayo Clinic Proceedings 2002, 77: 355-361. PMID: 11936931, DOI: 10.4065/77.4.355.Peer-Reviewed Original ResearchConceptsBreast cancerRisk factorsBreast cancer prevention clinical trialsCancer prevention clinical trialsPossible risk factorsPrevention clinical trialsRisk reductionRisk assessment toolLifestyle modificationProphylactic mastectomyClose surveillanceClinical trialsFamily historyCounseling womenNumerical risk estimatesCancerRisk estimatesIndividual riskSuch womenWomenRiskAbsence of consensusComplex family historiesAssessment toolOptions